In the wake of growing incidences of complex diseases such as autoimmune disorders, cardiovascular diseases, cancer, and more, healthcare industries across the globe are adopting new blood separation technologies and the apheresis equipment market is consequently expanding rapidly. As healthcare industries move toward advanced and specialized ways to deal with complicated diseases, apheresis finds a pivotal position in the market, where specific components can be filtered from blood and diseases are treated on a target-based approach.
Market size of apheresis equipment in terms of value stood at USD 3.0 Billion in 2025 and is predicted to be at USD 5.9 Billion in 2034 growing at a CAGR of 7.33% during the years 2026-2034 owing to advancement in technology, demand of blood components, and expanding therapeutic applications of apheresis in the different specialties of medicine.
Key Statistics
Base Year: 2025
Forecast Period: 2026–2034
Market Size (2025): USD 3.0 Billion
Market Forecast (2034): USD 5.9 Billion
CAGR (2026–2034): 7.33%
Leading Region: North America (35.0% market share)
Unlock Data-Driven Insights on the Apheresis Equipment Market – Access the IMARC Sample Report: https://www.imarcgroup.com/apheresis-equipment-market/requestsample
Market Highlights
Increasing demand for blood component separation and transfusion therapies
Rising adoption of therapeutic apheresis in chronic disease management
Continuous innovation in automated and high-precision equipment
Expanding use of apheresis in clinical trials and advanced therapies
Strong support from government initiatives and reimbursement policies
Market Growth Drivers
Rising Burden of Chronic and Autoimmune Diseases
The increasing incidence of chronic and autoimmune diseases is one of the most significant drivers of the apheresis equipment market. Conditions such as multiple sclerosis, lupus, rheumatoid arthritis, and various forms of cancer are becoming more prevalent globally, placing substantial pressure on healthcare systems to adopt effective treatment solutions.
Apheresis has emerged as a critical therapeutic intervention, particularly for patients who do not respond to conventional treatments. By selectively removing harmful components such as autoantibodies, immune complexes, and abnormal proteins from the bloodstream, apheresis provides targeted treatment with fewer side effects. As personalized medicine continues to gain traction, healthcare providers are increasingly incorporating apheresis into treatment protocols, further accelerating market growth.
Growing Demand for Blood Components and Transfusion Medicine
The demand for blood components such as plasma, platelets, and red blood cells is steadily increasing, driven by rising surgical procedures, trauma cases, and chronic disease treatments. Apheresis technology enables the selective collection of these components, improving efficiency compared to traditional whole blood donation methods.
Blood centers and hospitals are increasingly adopting apheresis systems to enhance supply chain efficiency and meet growing demand. This capability allows donors to contribute specific components more frequently, ensuring a stable and adequate supply for medical use. The growing importance of transfusion medicine is expected to continue driving the adoption of advanced apheresis equipment.
Technological Advancements Enhancing Efficiency and Safety
Technological innovation is transforming the apheresis equipment market, enabling the development of next-generation systems that offer improved automation, precision, and safety. Modern apheresis devices are equipped with real-time monitoring systems, intuitive user interfaces, and advanced software integration, allowing healthcare professionals to customize treatment parameters based on individual patient needs.
These advancements are not only improving clinical outcomes but also reducing the risk of human error and enhancing procedural efficiency. The introduction of portable and compact systems is further expanding the accessibility of apheresis technologies, enabling their use in smaller healthcare facilities and mobile blood donation units. Continuous investment in research and development is expected to drive further innovation in this space.
Expansion of Therapeutic Applications
The scope of apheresis is expanding beyond traditional blood component collection to include a wide range of therapeutic applications. It is increasingly being used in the treatment of neurological disorders, hematologic conditions, cardiovascular diseases, and metabolic disorders.
Healthcare providers are integrating apheresis into multidisciplinary treatment approaches, combining it with advanced therapies such as cell and gene therapy. This integration is particularly important in clinical trials, where precise blood component collection and processing are essential. As clinical research continues to explore new applications, the role of apheresis in modern medicine is expected to expand significantly.
Key Market Trends
Increased Adoption of Disposable Apheresis Kits
The growing preference for disposable apheresis kits is transforming clinical workflows and improving safety standards. These single-use kits reduce the risk of cross-contamination and eliminate the need for complex sterilization processes, ensuring a higher level of infection control.
Healthcare providers are increasingly adopting disposable kits to streamline operations and improve patient safety. These kits also enhance traceability and compliance with regulatory standards, making them a preferred choice in hospitals and blood centers. As demand for safe and efficient procedures continues to rise, the adoption of disposable kits is expected to increase further.
Integration of Advanced Technologies and Automation
The integration of advanced technologies, including automation and real-time monitoring, is a key trend shaping the market. Automated systems are enabling faster and more accurate procedures, reducing manual intervention and improving overall efficiency.
Manufacturers are focusing on developing user-friendly devices that can be easily operated by healthcare professionals, even in high-pressure clinical environments. These innovations are enhancing the reliability and scalability of apheresis procedures, supporting their widespread adoption across healthcare settings.
Growing Role in Cell and Gene Therapy
Apheresis is playing an increasingly important role in the development of cell and gene therapies, where precise blood component collection is critical. The technology is being used to collect cells for therapeutic applications, including CAR-T cell therapy and stem cell transplantation.
As the field of regenerative medicine continues to evolve, the demand for advanced apheresis systems is expected to grow. This trend is creating new opportunities for market players to develop specialized equipment tailored to emerging therapeutic applications.
Apheresis Equipment Market Segmentation
By Product
Disposable Apheresis Kits (72.2% Share)
Disposable kits dominate the market due to their role in ensuring safety, efficiency, and convenience. They reduce contamination risks and simplify clinical workflows, making them essential in modern healthcare settings.Apheresis Machine
These machines are integral to performing apheresis procedures and are continuously evolving with advanced features and improved performance capabilities.
By Application
Treatment (Leading Segment)
Therapeutic apheresis is widely used across multiple medical specialties, offering targeted treatment for complex conditions. It plays a crucial role in improving patient outcomes and managing disease progression.Blood Collection
Apheresis is extensively used in blood donation centers to collect specific components efficiently, supporting transfusion medicine.
By Procedure
Plasmapheresis (51.7% Share)
This procedure is widely used for removing harmful substances from the bloodstream, providing effective treatment for autoimmune and neurological disorders.Others
Includes plateletpheresis, leukapheresis, erythrocytapheresis, and photopheresis, each serving specific clinical purposes.
By Technology
Centrifugation (Leading Segment)
Centrifugation technology enables efficient separation of blood components, supporting both clinical and research applications.Membrane Filtration
Used for specialized applications requiring selective filtration of blood components.
By End User
Hospitals and Clinics (Leading Segment)
These facilities dominate the market due to their extensive use of apheresis in treatment and diagnostics.Blood Collection Centers
Focus on component collection for transfusion purposes.Others
Includes research institutions and specialized healthcare facilities.
By Region
North America (35.0%)
Dominates the market due to advanced healthcare infrastructure, high adoption of innovative technologies, and strong regulatory support.Europe
Growth driven by increasing prevalence of neurological disorders and strong clinical research environment.Asia Pacific
Rapid growth supported by expanding healthcare infrastructure and increasing blood donation activities.Latin America
Growth driven by improving healthcare systems and rising investment in medical facilities.Middle East and Africa
Increasing adoption due to expanding hospital networks and healthcare modernization efforts.
Explore Growth Opportunities in the Apheresis Equipment Market – Speak to an IMARC Analyst: https://www.imarcgroup.com/request?type=report&id=2387&flag=C
Key Regional Insights
North America leads due to advanced healthcare systems and reimbursement policies
Asia Pacific is emerging as a high-growth region
Europe driven by clinical research and neurological disorder treatments
MEA supported by healthcare infrastructure expansion
Competitive Landscape
The apheresis equipment market is characterized by strong competition and continuous innovation, with companies focusing on enhancing product performance and expanding their global presence.
Investment in advanced and automated technologies
Expansion of distribution networks in emerging markets
Strategic partnerships with healthcare providers
Focus on improving safety, efficiency, and compliance
Increasing mergers and acquisitions to strengthen capabilities
Key Market Players Include
Asahi Kasei Corporation
B. Braun Melsungen Aktiengesellschaft
Baxter International Inc.
Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
Haemonetics Corporation
Hemacare Corporation (Charles River Laboratories Inc.)
Kaneka Corporation
Kawasumi Laboratories Inc.
Medica SpA
Nikkiso Co Ltd.
Terumo BCT Inc. (Terumo Corporation)
Recent Industry Developments
June 2025: ImmunityBio secured FDA Expanded Access authorization for its Cancer BioShield™ platform powered by ANKTIVA®. The therapy targets lymphopenia in solid tumor patients following first-line treatment and utilizes apheresis-derived NK cells combined with IL-15 superagonists. Clinical data presented at ASCO 2025 demonstrated notable survival improvements in patients with advanced metastatic pancreatic cancer.
June 2025: Mandaya Royal Puri Hospital introduced apheresis services to treat blood cancers and autoimmune neurological disorders. The initiative focuses on reducing disease symptoms and is led by specialists in hematology and medical oncology.
June 2025: CTC partnered with OptiCell Solutions to advance cell and gene therapy research. The collaboration leverages sophisticated apheresis technologies to enable precise blood cell collection, streamline regulatory processes, and improve efficiency in isolating target cells for clinical applications.
May 2025: BBG Advanced Therapies launched the world’s first mobile leukapheresis center in San Antonio. Equipped with onboard apheresis units and a laboratory, the center expands access to cell and gene therapies and supports immune cell collection across a 63,000-square-mile service area for personalized treatment solutions.
April 2025: Asahi Kasei initiated operations of Asahi Kasei Life Science after transferring its apheresis-related business from Asahi Kasei Medical. The move aims to strengthen pharmaceutical manufacturing capabilities, while growing demand for products such as Planova™ and THESYS™ filtration systems is supported by facility expansions in the United States and Japan.
Future Outlook
The apheresis equipment market is expected to witness robust growth through 2034, supported by advancements in healthcare technologies and increasing demand for targeted therapies.
Rising adoption of personalized and precision medicine
Continued innovation in device automation and monitoring
Expansion of therapeutic applications
Increasing integration with advanced medical treatments
Apheresis Equipment Market FAQs
What is the growth outlook for the apheresis equipment market?
The apheresis equipment market is projected to grow steadily, driven by increasing demand for advanced therapeutic procedures and rising prevalence of chronic diseases.What are the key drivers of the apheresis equipment market?
Major drivers include growing incidence of autoimmune disorders, technological advancements in medical devices, and increasing demand for blood component collection.Which region dominates the apheresis equipment market?
North America leads the apheresis equipment market due to advanced healthcare infrastructure and strong adoption of innovative medical technologies.What are the major applications of apheresis equipment?
Apheresis equipment is widely used in treatment of neurological, hematological, and autoimmune diseases, as well as in blood component collection.Who are the key players in the apheresis equipment market?
Key players include leading medical device companies focusing on innovation, automation, and expansion of therapeutic applications.
About the Author:
IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Food & Beverages, Packaging, Chemicals and Materials, Healthcare, Technology, Agriculture, and more.
Media & Sales Contact:
IMARC Group
United States: +1-201-971-6302
India: +91-120-433-0800
United Kingdom: +44-753-714-6104
Comments
Log in or sign up to join the conversation.